20 annual accounts with figures on one time axis, 26 filings since 2000
peak of €291,594 in 2014
€64,935▼ 72.1%
lowest -€171,066 in 2018
€7.0m▲ 15×
peak of €8.5m in 2025
€8.5m▲ 391%
€413,563▲ 125%
Board2 names since 2007
2 directorsName hiddenVisible after signing in and 1 other
Documentsfilings and deeds
21-09-202652 days late
2025micro format
Gross margin from €232,856 to €64,935Result from €453,753 to €7.0mDividend €203,259Equity from €1.7m to €8.5mDebts from €183,520 to €413,563Cash from €8,359 to €146,076
Higher net result than 95% of companies in human health. The sector median is €59,520, over 21,372 companies.
Net result +1,440%: one-off income
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 1,587 companies had the same profile as SOBRAD has now. Each dot stands for 4 companies, two years later.
96.7%
were still trading
3.2%
stopped another way
0.1%
went bankrupt
Medium-sized
20 years or older
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,587 companies, not a prediction for SOBRAD. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Hidden nameVisible after signing in (director) and Name after signing inVisible after signing in (director) change roles
Discharge granted to Name hiddenVisible after signing in · Discharge granted to Hidden nameVisible after signing in · Gazette deed
Capital increase of €251,640 to €270,232.01
The capital rose from €18,592.01 to €270,232.01 · General meeting of 13-12-2013 · Gazette deed
Name after signing inVisible after signing in (manager) and Name hiddenVisible after signing in (manager) reappointed
“La société est constituée en vue de l'exercice de l'art de guérir dans le cadre des dispositions de la loi du…” (deed in French) · Capital of €18,592.01, 250 shares · General meeting of 28-09-2007 · Gazette deed
Incorporation
published on 23-02-2000 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as SOBRAD: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.9m and €6.8m, founded between 1998 and 2011.
The company number of SOBRAD is 0470.757.034. The VAT number is the same number with BE in front: BE 0470.757.034.
Where is SOBRAD based?
The registered office is at Rue d'Espinoy 10, 7500 Tournai.Company details
What does SOBRAD do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of SOBRAD?
SOBRAD is a private limited company (BV).
When was SOBRAD founded?
SOBRAD was founded on 11-02-2000.
Is SOBRAD still active?
Yes, SOBRAD is an active enterprise in the KBO register.
What is the turnover of SOBRAD?
The turnover in financial year 2025 is about €140,000. This figure is estimated from the gross margin of €64,935 and 33 comparable companies (NACE 862). It probably lies between €110,000 and €180,000.Financials
Is SOBRAD profitable?
In financial year 2025, SOBRAD made a profit of €7.0m.
Where can I find the annual accounts of SOBRAD?
SOBRAD filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SOBRAD due?
SOBRAD must file the annual accounts for financial year 2026 by 31-07-2027.Timeline